CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
Page 2 of 22 · 435 filings